Intravenous Administration of Factor VIII–O-Phospho-L-Serine (OPLS) Complex Reduces Immunogenicity and Preserves Pharmacokinetics of the Therapeutic Protein
European Journal of Pharmaceutical Sciences - Netherlands
doi 10.1016/j.ejps.2014.10.010
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2015
Authors
Publisher
Elsevier BV